Update on the Treatment of Salivary Gland Carcinomas.
Acinic cell carcinoma
Adenoid cystic carcinoma
Mucoepidermoid carcinoma
Salivary gland carcinoma
Salivary gland malignancy
Journal
Surgical oncology clinics of North America
ISSN: 1558-5042
Titre abrégé: Surg Oncol Clin N Am
Pays: United States
ID NLM: 9211789
Informations de publication
Date de publication:
Oct 2024
Oct 2024
Historique:
medline:
8
9
2024
pubmed:
8
9
2024
entrez:
7
9
2024
Statut:
ppublish
Résumé
Salivary gland carcinoma is a rare form of head and neck carcinoma, but it comprises a variety of subsites and histologic subtypes that each present with unique clinical courses and management challenges. Preoperative work-up generally consists of fine-needle aspiration cytology and MRI. However, because of the large variety of subtypes, there are often challenges obtaining a histologic diagnosis before surgery. Upfront surgery at the primary site leads to the greatest improvement in survival. Posttreatment surveillance of these patients is important. This article discusses some of the current controversies in the management of salivary gland carcinomas.
Identifiants
pubmed: 39244292
pii: S1055-3207(24)00033-4
doi: 10.1016/j.soc.2024.04.008
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
747-760Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.